ACM
Atika Capital Management Portfolio holdings
AUM
$634M
1-Year Est. Return
167.57%
This Fund
S&P 500
1 Year Est. Return
+167.57%
AUM
$634M
AUM Growth
-$84.5M
(-12%)
Holding
90
Top Buys
| 1 | +$9.85M | |
| 2 | +$8.73M | |
| 3 | +$7.99M | |
| 4 |
VanEck Gold Miners ETF
GDX
|
+$7.88M |
| 5 |
Vertiv
VRT
|
+$6.66M |
Top Sells
| 1 | +$20M | |
| 2 | +$19.8M | |
| 3 | +$13.5M | |
| 4 |
Insmed
INSM
|
+$13.4M |
| 5 |
DoorDash
DASH
|
+$10.4M |
Sector Composition
| 1 | Industrials | 40.1% |
| 2 | Healthcare | 29.49% |
| 3 | Technology | 13.72% |
| 4 | Communication Services | 8.96% |
| 5 | Consumer Discretionary | 4.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
United Therapeutics
UTHR
$23.4B
| $7.32M | 1.16% |
+12,350
|
|
||
|
KRMN
27
Karman Holdings
KRMN
$6.86B
| $7.24M | 1.14% |
+90,500
|
|
||
28
Ferguson
FERG
$44B
| $6.83M | 1.08% |
29,300
|
|
||
29
Protagonist Therapeutics
PTGX
$6.19B
| $6.55M | 1.03% |
62,100
-23,900
|
|
||
30
Clean Harbors
CLH
$15.3B
| $6.27M | 0.99% |
21,855
+18,855
|
|
||
|
TLN
31
Talen Energy Corp
TLN
$17B
| $5.9M | 0.93% |
18,490
-23,610
|
|
||
32
Immunome
IMNM
$2.26B
| $5.75M | 0.91% |
262,900
-71,441
|
|
||
33
Meta Platforms (Facebook)
META
$1.61T
| $5.72M | 0.9% |
+10,000
|
|
||
|
DBVT
34
DBV Technologies
DBVT
$1.01B
| $5.67M | 0.89% |
271,300
+64,419
|
|
||
35
Rocket Lab Corp
RKLB
$65.5B
| $5.52M | 0.87% |
86,000
+23,885
|
|
||
36
HEICO Corp
HEI
$46.6B
| $5.28M | 0.83% |
19,265
-7,035
|
|
||
|
QXO
37
QXO Inc
QXO
$12B
| $5.13M | 0.81% |
264,253
-155,747
|
|
||
38
SiTime
SITM
$18.1B
| $5.11M | 0.81% |
+14,805
|
|
||
39
GE Aerospace
GE
$332B
| $4.4M | 0.69% |
15,510
-10,438
|
|
||
40
Ascendis Pharma A/S
ASND
$13.5B
| $4.37M | 0.69% |
19,125
-1,517
|
|
||
41
The RealReal
REAL
$1.11B
| $4.1M | 0.65% |
451,055
-113,945
|
|
||
42
nLIGHT
LASR
$4.09B
| $3.76M | 0.59% |
+66,000
|
|
||
43
Xenon Pharmaceuticals
XENE
$5.2B
| $3.48M | 0.55% |
59,900
-32,606
|
|
||
44
BBB Foods
TBBB
$5.23B
| $3.37M | 0.53% |
95,218
-47,064
|
|
||
|
MAZE
45
Maze Therapeutics
MAZE
$1.38B
| $3.33M | 0.53% |
+111,500
|
|
||
|
ABVX
46
Abivax
ABVX
$7.57B
| $3.21M | 0.51% |
28,800
-26,200
|
|
||
47
Acadia Healthcare
ACHC
$2.39B
| $2.87M | 0.45% |
+122,600
|
|
||
48
Warby Parker
WRBY
$2.99B
| $2.84M | 0.45% |
135,000
-113,971
|
|
||
49
Krystal Biotech
KRYS
$8.9B
| $2.74M | 0.43% |
+10,625
|
|
||
50
BridgeBio Pharma
BBIO
$12.9B
| $2.61M | 0.41% |
+35,200
|
|